ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Xiaoyan Zhu
Matched on ORCID iD 0000-0003-2771-0240; OpenAlex author ID A5100452983. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 5
- Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal aden… Co-author DOI 10.1038/s41392-024-02052-3↗
- Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis. Co-author DOI 10.1186/s12957-023-03140-4↗
- Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter coh… Co-author DOI 10.18632/oncotarget.13000↗
- Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. Co-author DOI 10.3892/mmr.2016.5471↗
- Metastatic adenocarcinoma of the epididymis from pancreatic cancer successfully treated by chemotherapy and high-intensity focused ultrasound therapy: a case r… Co-author DOI 10.1097/mpa.0b013e318221816d↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhiqiang Meng · 4 shared papers, 2011–2024 · strength 0.33
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3↗
- Paper Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. DOI 10.3892/mmr.2016.5471↗
- Paper Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? … DOI 10.18632/oncotarget.13000↗
- Zhouyu Ning · 3 shared papers, 2016–2024 · strength 0.30
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3↗
- Paper Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. DOI 10.3892/mmr.2016.5471↗
- Paper Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? … DOI 10.18632/oncotarget.13000↗
- Shu Dong Ma · 2 shared papers, 2016–2023 · strength 0.26
- Paper Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver me… DOI 10.1186/s12957-023-03140-4↗
- Paper Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? … DOI 10.18632/oncotarget.13000↗
- Jing Xie · 2 shared papers, 2016–2024 · strength 0.22
- Paper Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliar… DOI 10.1038/s41392-024-02052-3↗
- Paper Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? … DOI 10.18632/oncotarget.13000↗
- Hao Chen · 1 shared paper, 2023 · strength 0.22
- Xian Miao · 1 shared paper, 2023 · strength 0.22
- Lixia Yi · 1 shared paper, 2024 · strength 0.18
- Waimei Si · 1 shared paper, 2024 · strength 0.18
- Yifan Yang · 1 shared paper, 2024 · strength 0.18
- Haiyong Wang · 1 shared paper, 2016 · strength 0.08
- Ying-Yi Li · 1 shared paper, 2016 · strength 0.08
- Luming Liu · 2 shared papers, 2011–2016 · strength 0.07
- Paper Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? … DOI 10.18632/oncotarget.13000↗
- Paper Metastatic adenocarcinoma of the epididymis from pancreatic cancer successfully treated by chemotherapy and high-intens… DOI 10.1097/mpa.0b013e318221816d↗
- Zhen Chen · 2 shared papers, 2011–2016 · strength 0.07
- Paper Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? … DOI 10.18632/oncotarget.13000↗
- Paper Metastatic adenocarcinoma of the epididymis from pancreatic cancer successfully treated by chemotherapy and high-intens… DOI 10.1097/mpa.0b013e318221816d↗
- Yongqiang Hua · 1 shared paper, 2016 · strength 0.04
- Yehua Shen · 1 shared paper, 2016 · strength 0.04
- Lei Wang · 1 shared paper, 2016 · strength 0.04
- Lanyun Feng · 1 shared paper, 2016 · strength 0.04
- Chenyue Zhang · 1 shared paper, 2016 · strength 0.04
- Zhao‐Shen Li · 1 shared paper, 2016 · strength 0.04
- Hao Chen · 1 shared paper, 2016 · strength 0.04
- Yuanbiao Guo · 1 shared paper, 2016 · strength 0.04
- Jinming Yu · 1 shared paper, 2016 · strength 0.04
- Weidong Shi · 1 shared paper, 2016 · strength 0.04
- Qiwen Chen · 1 shared paper, 2016 · strength 0.04
- Lianyu Chen · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.